Neonatal Hypoglycemia

Treatment with metformin plus glyburide was not noninferior to insulin alone in preventing large for gestational age infants born from pregnant women with gestational diabetes, according to trial results published in JAMA.

Women with mild chronic hypertension induced at 37 weeks’ gestation saw no reduction in adverse maternal outcomes compared with women delivered at 39 weeks, but did experience increases in some neonatal complications, data show.

Pregnant women with type 2 diabetes who used continuous glucose monitoring only had improvements in CGM metrics if they used the device more than 50% of the time, according to data published in Diabetes Technology & Therapeutics.

By reducing HbA1c during pregnancy, women with pregestational diabetes may reduce their risks for having an infant born large for gestational age or with neonatal hypoglycemia, according to study results published in Diabetic Medicine.

An elevated HbA1c that is still in the prediabetes range was associated with increased risk for neonatal hypoglycemia, particularly among white infants born prematurely, data show.

More pregnant Japanese women have been diagnosed with gestational diabetes and fewer births have resulted in neonatal hypoglycemia since Japan adopted new criteria for diagnosing the condition in 2010, according to findings published in the Journal of Diabetes Investigation.

Missing a type 2 diabetes diagnosis before pregnancy may lead to complications during pregnancy and delivery for mothers and their children, according to findings published in Diabetic Medicine.

Children born via early term scheduled cesarean section to women with any type of diabetes may be at greater risk for neonatal hypoglycemia if their mother is treated with corticosteroids, according to findings published in Diabetes Care.